Nektar Therapeutics (ITH.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:03AM CEST. Market open.
| Previous Close | 1.2450 |
| Open | 1.2110 |
| Bid | 1.2350 x 50000 |
| Ask | 1.2360 x 50000 |
| Day's Range | 1.2110 - 1.2110 |
| 52 Week Range | 0.3901 - 1.5460 |
| Volume | |
| Avg. Volume | 2,396 |
| Market Cap | 222.361M |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.3700 |
| Earnings Date | May 07, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.08 |
ZacksNektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR NewswireNektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at the upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 28, 2024 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time.
ZacksNektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
The placebo-controlled, phase IIb study will investigate the efficacy and safety of Nektar's (NKTR) rezpeg in patients with severe to very severe alopecia areata.
© 2024 Yahoo. All rights reserved.